The HSV-1 gene is injected locally and transferred into tumor cells to grow and produce human granulocyte macrophage colony-stimulating factor. The drug breaks up tumor cells, releases tumor antigens, and activates systemic antitumor and effector T cell responses. The gene discussed is CSF2; the disease is neoplasm.